FDA Approves KV's Drug Manufacturing Plan
The U.S. Food and Drug Administration has signed off on KV Pharmaceutical Co.'s work plan that aims to clear up problems with its drug manufacturing and distribution practices, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article